CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0756

FOXO4

Filed under Peptides. The bureau holds 56 laboratory returns for this compound from 18 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

18 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693A510.09.910.014 Nov 202516 Apr 2026
HomopeptideCASE #VI-2026-0760A59.99.99.923 May 202623 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A69.07.69.924 May 202624 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A88.67.09.524 May 202624 May 2026
Atomik LabzCASE #VI-2026-0327X28.48.08.811 Jun 202519 Jan 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A58.37.79.123 May 202623 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A48.27.89.024 May 202624 May 2026
Zenith Jove Peptide ZJCASE #VI-2026-0570X28.17.38.827 Feb 202519 Jan 2026
InjectifyCASE #VI-2026-0387X18.18.18.17 May 20257 May 2025
Skye PeptidesCASE #VI-2026-0451X68.06.88.920 Jun 202521 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A37.96.38.724 May 202624 May 2026
BeiBangAnCASE #VI-2026-0899X17.87.87.811 Jun 202511 Jun 2025
LN PeptidesCASE #VI-2026-0781X27.27.17.228 Mar 202524 May 2026
Xingtai Lesda TechnologyCASE #VI-2026-0381X17.17.17.13 Jun 20253 Jun 2025
TydesCASE #VI-2026-0493X27.06.87.321 May 202519 Jan 2026
Xingtai Jiachuang TechnologyCASE #VI-2026-0712X16.86.86.827 Feb 202527 Feb 2025
Mix PeptidesCASE #VI-2026-0699X26.24.87.62 Jul 202523 May 2026
Shaanxi Dideu MedichemCASE #VI-2026-0499X15.35.35.313 Feb 202513 Feb 2025

Open any subject to view the batch-level evidence for FOXO4 alone.